| |
|
|
|
Capricor Therapeutics Inc.  
|
|
0.920059 0.04 (0.05%) |
11-16 15:58 |
|
Open: |
0.89 |
Pre close: |
0.88 |
Target:
|
1.12
|
|
High: |
0.95 |
Low: |
0.8801 |
Resistance:
|
0.96
1.15
|
|
Volume: |
21,725 |
Market Cap: |
28M |
Support:
|
0.66
0.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.90
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.90  |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
1.10 |
Stochastic Oscillator |
%K(14,3):
|
44.40 |
|
MA(250): |
1.39 |
%D(3): |
47.23 |
|
Average Volume(K) |
3-Month: |
12756
|
52-Week |
High:
|
2.48 |
|
10-Days: |
7596 |
Low: |
0.66 |
|
RSI |
RSI(14):
|
44.57 |
Change(%): |
-59.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.510 |
Return on Equity (ttm) |
116.6 |
Shares Out. (M) |
30.75 |
|
EPS Est. Current Year |
-0.700 |
Return on Assets (ttm) |
12.4 |
Shares Float (M) |
27.07 |
|
EPS Est. Next Year |
-0.760 |
PEG Ratio |
0.00 |
% Held by Insiders |
13.30 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
-59.5 |
% Held by Institutions |
15.30 |
|
Forward EPS |
-0.430 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.220 |
EBITDA (p.s.) |
-0.084 |
P/E |
-1.74 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.28 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.97 |
P/S |
455603072.00 |
|
Operating Margin |
-864.19 |
Levered Free Cash Flow
(M) |
-8.03 |
P/CF |
-2.10 |
|
|
|
|
|
|
